ArticlePlastic and reconstructive surgery. Global open2026
Defining the Vascular Anomalies in Maffucci Syndrome: A Systematic Review.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maffucci syndrome (MS) is a rare disorder characterized by enchondromas and vascular anomalies (VAs). However, the nomenclature used to define MS in the literature is variable. The purpose of this review is to evaluate definitions of MS and characterize VAs reported in patients with MS, in relation to International Society for the Study of Vascular Anomalies (ISSVA) definitions. Methods: MEDLINE and Embase were searched for articles that discussed MS. Articles were analyzed for VAs identified in the disease definition. Case reports of MS were analyzed for VAs diagnosed in their patients. Results: Since 1950, 265 articles have defined MS. Disease definitions have varied widely. Over half of the articles identified "hemangioma" nonspecifically as the defining VA, whereas only 2 recognized the ISSVA definition of MS as "enchondromas with venous malformations ± spindle-cell hemangiomas (SCHs)." Of 220 patients in 183 primary reports, only 36 (16%) patients had a VA diagnosis consistent with a specific ISSVA diagnostic label. Only 9 (4%) patients were reported to have venous malformations per the 2018 ISSVA definition of MS, whereas 23 (11%) were reported to have SCHs in the absence of venous malformations. Conclusions: The definition of MS remains inconsistent due to the use of ambiguous and outdated nomenclature for classifying VAs. This makes it difficult to identify the true constellation of VAs present in the disease. Clinicians and researchers should adhere to modern nomenclature when discussing VAs. Given multiple histologically confirmed SCHs in the absence of venous malformations, it seems that either lesion may be diagnostic for MS.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.